Skip to main content
KALA
NASDAQ Life Sciences

Kala Bio Finalizes Exclusive U.S. Distribution Deal for Ophthalmology Genetic Testing

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.538
Mkt Cap
$10.105M
52W Low
$0.503
52W High
$1,030
52W Position info
7.0% above low
Off High info
100% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

KALA is trading near its 52-week low of $0.503 (7.0% above the low).

Summary

Kala Bio has converted its September 1 letter of intent with Virotek into a definitive exclusive U.S. distribution agreement for Virotek's ophthalmology genetic testing program. The one-year exclusivity is contingent on Kala hitting commercial milestones, and the companies will share profits after Virotek recoups program costs. Kala also gets a right of first refusal on certain Virotek ophthalmology products and a framework to expand into oncology, preventive health, telehealth, and white-label channels. This is a meaningful step for a company with a market cap around $10 million and cash under $0.1 million, as it adds a potential revenue stream without upfront capital. However, no revenue projections are provided, and Kala faces Nasdaq delisting and going-concern risks. The deal's success hinges on Kala's ability to execute commercially while managing its liquidity constraints.

At the time of this announcement, KALA was trading at $0.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.1M. The 52-week trading range was $0.50 to $1,030.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

KALA - Latest Insights

KALA
Sep 29, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.474
Real-time Price: $0.1698 info
Change: -$0.3042 (-64%) info
Market Cap: $3.234M info
KALA
Sep 24, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.5288
Real-time Price: $0.1698 info
Change: -$0.359 (-68%) info
Market Cap: $3.234M info
KALA
Sep 11, 2026, 4:56 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.590
Real-time Price: $0.1698 info
Change: -$0.4202 (-71%) info
Market Cap: $3.234M info
KALA
Aug 28, 2026, 6:45 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.795
Real-time Price: $0.1698 info
Change: -$0.6252 (-79%) info
Market Cap: $3.234M info
KALA
Aug 19, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.900
Real-time Price: $0.1698 info
Change: -$0.7302 (-81%) info
Market Cap: $3.234M info